Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06339034 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Repurposing Lithium for Parkinson's Disease: a RCT

StatusActive, Not Recruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 16, 2026 (before its estimated August 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 2025 to Aug 2026
    • Study completion date: Feb 2026 to Sep 2026
    v4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Aug 2025 to Dec 2025
    • Study completion date: Oct 2025 to Feb 2026
    • Site details revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 2024 to Jul 3, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.
Trial Details
NCT Number NCT06339034
Lead Sponsor State University of New York at Buffalo
Collaborators: Cure Parkinson's
Conditions
(from sponsor)		 Parkinson Disease
Related terms Parkinson Disease
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov